ACET
Income statement / Annual
Last year (2023), Adicet Bio, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Adicet Bio, Inc.'s net income was -$142.66 M.
See Adicet Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
06/30/2014 |
| Operating Revenue |
$0.00
|
$24.99 M
|
$9.73 M
|
$17.90 M
|
$995,000.00
|
$8.18 M
|
$558.52 M
|
$546.95 M
|
$510.18 M
|
$499.69 M
|
| Cost of Revenue |
$6.10 M |
$5.01 M |
$0.00 |
$0.00 |
$125,000.00 |
$80,000.00 |
$5,000.00 |
$411.52 M |
$395.48 M |
$401.42 M |
| Gross Profit |
-$6.10 M |
$19.98 M |
$9.73 M |
$17.90 M |
$870,000.00 |
$8.10 M |
$558.52 M |
$135.43 M |
$114.70 M |
$98.27 M |
| Gross Profit Ratio |
0 |
0.8 |
1 |
1 |
0.87 |
0.99 |
1 |
0.25 |
0.22 |
0.2 |
| Research and Development
Expenses |
$106.04 M
|
$71.25 M
|
$48.94 M
|
$34.33 M
|
$23.69 M
|
$14.72 M
|
$16.84 M
|
$5.94 M
|
$5.22 M
|
$2.83 M
|
| General & Administrative
Expenses |
$26.53 M
|
$26.30 M
|
$22.22 M
|
$22.76 M
|
$8.69 M
|
$8.43 M
|
$76.82 M
|
$73.16 M
|
$65.21 M
|
$61.02 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$74.78 M
|
-$73.16 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$26.53 M
|
$26.30 M
|
$22.22 M
|
$22.76 M
|
$8.69 M
|
$8.43 M
|
$2.04 M
|
$1,000.00
|
$65.21 M
|
$61.02 M
|
| Other Expenses |
$19.46 M |
-$919,000.00 |
-$606,000.00 |
-$953,000.00 |
$2.33 M |
$4.53 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$152.04 M |
$97.54 M |
$71.16 M |
$57.09 M |
$32.38 M |
$23.15 M |
$18.88 M |
$1,000.00 |
$70.43 M |
$63.86 M |
| Cost And Expenses |
$152.04 M |
$97.54 M |
$71.16 M |
$57.09 M |
$32.38 M |
$23.15 M |
$18.88 M |
$1,000.00 |
$465.91 M |
$465.27 M |
| Interest Income |
$9.95 M |
$3.76 M |
$91,000.00 |
$785,000.00 |
$938,000.00 |
$543,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$80,000.00 |
$176,000.00 |
$134,000.00 |
$0.00 |
$0.00 |
$7.00 M |
$3.95 M |
$2.10 M |
$2.12 M |
| Depreciation &
Amortization |
$6.10 M
|
$5.01 M
|
$4.07 M
|
$1.95 M
|
$1.24 M
|
$80,000.00
|
$5,000.00
|
$11.85 M
|
$8.09 M
|
$6.94 M
|
| EBITDA |
-$136.54 M
|
-$64.70 M
|
-$60.41 M
|
-$37.41 M
|
-$26.88 M
|
-$13.74 M
|
-$33.77 M
|
-$1,000.00
|
$54.87 M
|
$43.62 M
|
| EBITDA Ratio |
0 |
-2.79 |
-6.37 |
-2.2 |
-27.02 |
-1.06 |
-0.03 |
-0 |
0.11 |
0.09 |
| Operating Income Ratio
|
0
|
-2.9
|
-6.31
|
-2.19
|
-31.55
|
-1.83
|
-0.03
|
-0
|
0.09
|
0.07
|
| Total Other
Income/Expenses Net |
$9.38 M
|
$2.76 M
|
-$691,000.00
|
-$302,000.00
|
$3.27 M
|
$5.08 M
|
-$14.90 M
|
$0.00
|
$402,000.00
|
$134,000.00
|
| Income Before Tax |
-$142.66 M |
-$69.79 M |
-$62.12 M |
-$39.49 M |
-$28.12 M |
-$9.89 M |
-$33.78 M |
-$1,000.00 |
$44.67 M |
$34.55 M |
| Income Before Tax Ratio
|
0
|
-2.79
|
-6.38
|
-2.21
|
-28.26
|
-1.21
|
-0.06
|
-0
|
0.09
|
0.07
|
| Income Tax Expense |
$0.00 |
-$2.76 M |
-$125,000.00 |
-$2.82 M |
$19,000.00 |
-$589,000.00 |
$19.09 M |
$20.38 M |
$15.67 M |
$12.22 M |
| Net Income |
-$142.66 M |
-$67.03 M |
-$62.00 M |
-$36.68 M |
-$28.14 M |
-$9.30 M |
-$33.78 M |
-$1,000.00 |
$29.00 M |
$22.33 M |
| Net Income Ratio |
0 |
-2.68 |
-6.37 |
-2.05 |
-28.28 |
-1.14 |
-0.06 |
-0 |
0.06 |
0.04 |
| EPS |
-3.31 |
-1.63 |
-2 |
-5.01 |
-1.52 |
-0.31 |
-1.26 |
0 |
1.18 |
0.94 |
| EPS Diluted |
-3.31 |
-1.63 |
-2 |
-5.01 |
-1.52 |
-0.31 |
-1.25 |
0 |
1.16 |
0.93 |
| Weighted Average Shares
Out |
$43.04 M
|
$41.08 M
|
$30.95 M
|
$7.32 M
|
$18.56 M
|
$29.80 M
|
$26.77 M
|
$28.05 M
|
$24.50 M
|
$23.67 M
|
| Weighted Average Shares
Out Diluted |
$43.04 M
|
$41.08 M
|
$30.95 M
|
$7.32 M
|
$18.56 M
|
$29.80 M
|
$26.97 M
|
$28.05 M
|
$24.99 M
|
$24.02 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
